A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.

MLA

Westermann, A. M., et al. “A Systemic Hyperthermia Oncologic Working Group Trial. Ifosfamide, Carboplatin, and Etoposide Combined with 41.8 Degrees C Whole-Body Hyperthermia for Metastatic Soft Tissue Sarcoma.” Oncology, vol. 64, no. 4, 2003, pp. 312–21. EBSCOhost, https://doi.org/10.1159/000070287.

APA

Westermann, A. M., Wiedemann, G. J., Jager, E., Jager, D., Katschinski, D. M., Knuth, A., Vörde Sive Vörding, P. Z., Van Dijk, J. D. P., Finet, J., Neumann, A., Longo, W., Bakhshandeh, A., Tiggelaar, C. L., Gillis, W., Bailey, H., Peters, S. O., & Robins, H. I. (2003). A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology, 64(4), 312–321. https://doi.org/10.1159/000070287

Chicago

Westermann, A M, G J Wiedemann, E Jager, D Jager, D M Katschinski, A Knuth, P Z Vörde Sive Vörding, et al. 2003. “A Systemic Hyperthermia Oncologic Working Group Trial. Ifosfamide, Carboplatin, and Etoposide Combined with 41.8 Degrees C Whole-Body Hyperthermia for Metastatic Soft Tissue Sarcoma.” Oncology 64 (4): 312–21. doi:10.1159/000070287.